Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination

被引:3
|
作者
Llaneras, Jordi [1 ]
Ruiz-Cobo, Juan Carlos [2 ]
Rando-Segura, Ariadna [3 ,4 ]
Barreira-Diaz, Ana [2 ]
Dominguez-Hernandez, Raquel [5 ]
Rodriguez-Frias, Francisco [4 ,6 ]
Campins, Magda [7 ]
Colom, Joan [8 ]
Casado, Miguel Angel [4 ,5 ]
Blanco-Grau, Albert [6 ]
Banares, Juan [2 ]
Monforte, Arnau
Falco-Roget, Anna [9 ]
Ruiz, Lourdes [2 ]
Meza, Beatriz [1 ]
Pumarola, Tomas [3 ]
Riveiro-Barciela, Mar [2 ,4 ]
Esteban, Rafael [2 ,4 ]
Buti, Maria [2 ,4 ,10 ]
机构
[1] Hosp Univ Vall Dhebron, Emergency Dept, Barcelona, Spain
[2] Hosp Univ Vall Dhebron, Liver Unit, Barcelona, Spain
[3] Hosp Univ Vall Dhebron, Microbiol Dept, Barcelona, Spain
[4] Inst Salud Carlos III, CIBEREHD, Madrid, Spain
[5] Pharmacoecon & Outcomes Res Iberia PORIB, Madrid, Spain
[6] Hosp Univ Vall Dhebron, Biochem Dept, Barcelona, Spain
[7] Hosp Univ Vall Dhebron, Epidemiol Serv, Barcelona, Spain
[8] Hlth Dept, Publ Hlth Agcy Catalonia, Gen Subdirect Prevent Control & Care Addict HIV ST, Barcelona, Spain
[9] Hosp Univ Vall Dhebron, Infect Dis Dept, Barcelona, Spain
[10] Vall Dhebron 119, Barcelona 08035, Spain
关键词
HBV; HCV; HDV; Mass screening; Emergency service; Cost-effectiveness analysis; ECONOMIC-EVALUATION; COST-EFFECTIVENESS; C VIRUS;
D O I
10.1016/j.jhepr.2023.100932
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Many people with HCV and HBV infection are unaware of their condition, particularly at-risk and vulnerable populations who face barriers for screening and linkage to care. Emergency departments are often their only point of contact with the health system. Methods: This is a prospective study investigating HBsAg and HCV antibody testing, with reflex testing for HDV antibodies and HCV RNA, in adults attending an emergency department and requiring a blood test. Positive cases were linked to care. A cost-effectiveness analysis was performed. Results: From February 2020 to February 2022, a total of 17,560 individuals were screened. HBsAg was detected in 91 (0.5%), HCV RNA in 128 (0.7%), and HDV antibodies in two (0.01%) individuals. Nearly 40% of positive cases were unaware of their condition. Linkage to care was achieved in 42 of 56 HBsAg-positive and 45 of 69 HCV RNA-positive participants who were candidates for referral. HCV and HBV screening vs. no screening yielded 1.06 and 0.42 additional quality-adjusted life-years, respectively, with incremental cost-utility ratios of euro7,629 and-euro147 per quality-adjusted life-year gained, respectively, and proved even more cost-effective in patients with hepatitis C aged 40-70 years. Conclusions: On emergency department screening for hepatitis B, C, and D in Barcelona, the prevalence of HBsAg was 0.5% and HCV RNA 0.7%, approximately threefold higher than that observed in the general population. This strategy diagnosed patients with active HCV infection and no risk factors, who would not have been screened according to the current rec-ommendations. Screening and linkage to care of viral hepatitis is cost-effective in this setting. Impact and implications: We evaluated the performance and cost-effectiveness of a viral hepatitis screening programme implemented in an emergency department, which aimed to identify and link to care people living with hepatitis B and C. Our findings reveal a threefold higher prevalence of hepatitis B and C than in the general Spanish population, possibly attributable to the role of the emergency department as the main healthcare gateway for vulnerable populations, who have a higher prevalence of viral hepatitis. Risk factors for viral hepatitis could not be identified in most people living with hepatitis B and C attending the emergency department; hence, screening beyond risk factors should be considered in hepatitis detection strategies. Emergency department screening is cost-effective for hepatitis C and is a cost-saving strategy for hepatitis B in our setting. These data should inform future updates to clinical guidelines. (c) 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Towards Elimination of Viral Hepatitis
    Davila, Mila Gonzalez
    Polanco, Victor Puac
    Santaella, Julian
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (08) : 1350 - 1350
  • [2] Towards elimination of viral hepatitis by 2030
    不详
    LANCET, 2016, 388 (10042): : 308 - 308
  • [3] Viral hepatitis elimination: Towards a hepatitis-free world
    Buti, Maria
    Craxi, Antonio
    Foster, Graham R.
    Maticic, Mojca
    Negro, Francesco
    Zeuzem, Stefan
    Zoulim, Fabien
    JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1444 - 1447
  • [4] Progress towards elimination goals for viral hepatitis
    Cox, Andrea L.
    El-Sayed, Manal H.
    Kao, Jia-Horng
    Lazarus, Jeffrey V.
    Lemoine, Maud
    Lok, Anna S.
    Zoulim, Fabien
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (09) : 533 - 542
  • [5] Progress towards elimination goals for viral hepatitis
    Andrea L. Cox
    Manal H. El-Sayed
    Jia-Horng Kao
    Jeffrey V. Lazarus
    Maud Lemoine
    Anna S. Lok
    Fabien Zoulim
    Nature Reviews Gastroenterology & Hepatology, 2020, 17 : 533 - 542
  • [6] A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination
    Crespo, Javier
    Calleja, Jose Luis
    Cabezas, Joaquin
    Garcia, Federico
    Aguilera, Antonio
    Jorquera, Francisco
    Lazarus, Jeffrey V.
    LIVER INTERNATIONAL, 2023, 43 (05) : 1145 - 1147
  • [7] Towards the elimination of viral hepatitis in Thailand by the year 2030
    Posuwan, Nawarat
    Wanlapakorn, Nasamon
    Sintusek, Palittiya
    Wasitthankasem, Rujipat
    Poovorawan, Kittiyod
    Vongpunsawad, Sompong
    Poovorawan, Yong
    JOURNAL OF VIRUS ERADICATION, 2020, 6 (03)
  • [8] Capacity building of healthcare workers: Key step towards elimination of viral hepatitis in developing countries
    Rastogi, Aayushi
    Chauhan, Sapna
    Ramalingam, Archana
    Verma, Madhavi
    Babu, Seena
    Ahwal, Sarita
    Bansal, Akanksha
    PLOS ONE, 2021, 16 (06):
  • [9] MANAGEMENT OF VIRAL HEPATITIS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1962, (5317): : 1454 - +
  • [10] MANAGEMENT OF VIRAL HEPATITIS
    FREEMAN, AG
    BRITISH MEDICAL JOURNAL, 1962, (5319): : 1619 - &